White House may need to scale back booster shot plan

Pfizer vaccne
(Image credit: JOSEPH PREZIOSO/AFP via Getty Images)

The Biden administration last month unveiled plans to start offering COVID-19 booster shots to all Americans beginning on Sept. 20. But officials are reportedly now weighing whether this plan will have to be scaled back.

Top health officials are urging the White House to scale back the COVID-19 booster shot plan because more time is needed to review the data, The New York Times reported. CNN also reported that the Biden administration is discussing whether to scale the plan back, citing an official as saying the FDA doesn't currently have enough data to recommend a third dose of the Moderna vaccine. "The officials warned that more time may be needed before enough data is in to recommend boosters for all adults," CNN writes. Data that Moderna recently submitted was "found inadequate and needs strengthening," an official said, NBC News reports.

When announcing the booster rollout plan last month, top health officials said the administration was "prepared to offer booster shots for all Americans beginning the week of September 20" subject to FDA approval. The booster shots, the officials said, would be offered starting eight months after an individual received their second dose, though The Wall Street Journal later reported that regulators would likely approve the shots after six months.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.


Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

A White House spokesperson told the Times that "we always said we would follow the science, and this is all part of a process that is now underway." The spokesperson added that when the booster shots received "full review and approval" from the FDA, the administration "will be ready to implement the plan our nation's top doctors developed so that we are staying ahead of this virus."

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us